Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study

by Muller, D C, Giles, G G, Manning, J T, Hopper, J L, English, D R, Severi, G
Published 2011

The effect of age and breast density on the sensitivity of mammography

by Kavanagh, AM, Byrnes, GB, Hopper, J, Giles, GG, Gertig, DM, Cawson, JN, Marr, G
Published 2004

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography

by Kavanagh, AM, Cawson, JN, Byrnes, GB, Giles, GG, Marr, G, Gertig, DM, Hopper, J
Published 2004

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance

by Parsons, M, Thompson, B, Goldgar, D, Hopper, J, Jenkins, M, Buchanan, D, Young, J, Spurdle, A
Published 2012

Validation study of risk prediction models for female relatives of Australian women with breast cancer

by MacInnis, R, Dite, G, Bickerstaffe, A, Dowty, J, Aujard, K, Apicella, C, Phillips, K, Weideman, P, Hopper, J
Published 2012

‘Next-generation’ genome wide association studies

by Hopper, J, Makalic, E, Schmidt, D, Bui, M, Stone, J, Kapuscinski, M, Park, D, Jenkins, M, Southey, M
Published 2012

Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants

by Thompson, B, Goldgar, D, Paterson, C, Clendenning, M, Walters, R, Arnold, S, Parsons, M, Walsh, M, Hopper, J, Jenkins, M, Greenblatt, M, Buchanan, D, Young, J, Tavtigian, S, Spurdle, A
Published 2012

Second to fourth digit ratio (2D : 4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study

by Muller, D C, Baglietto, L, Manning, J T, McLean, C, Hopper, J L, English, D R, Giles, G G, Severi, G
Published 2012

Reply to comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'

by Muller, D C, Baglietto, L, Manning, J T, McLean, C, Hopper, J L, English, D R, Giles, G G, Severi, G
Published 2013

Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer

by Barnes, D R, Barrowdale, D, Beesley, J, Chen, X, James, P A, Hopper, J L, Goldgar, D, Chenevix-Trench, G, Antoniou, A C, Mitchell, G
Published 2013

A comparison of self-reported and record-linked blood donation history in an Australian cohort

by Bertalli, N., Allen, K., McLaren, C., Turkovic, L., Osborne, N., Constantine, C., Delatycki, M., English, D., Giles, G., Hopper, J., Anderson, G., Olynyk, John, Powell, L., Gurrin, L.
Published 2011

HFE C282Tyr homozygotes with serum ferritin concentrations below 100ug/L are at low risk of hemochromatosis

by Allen, K., Bertalli, N., Osborne, N., Constantine, C., Delatycki, M., Nisselle, A., Nicoll, A., Gertig, D., McLaren, C., Giles, G., Hopper, J., Anderson, G., Olynyk, John, Powell, L., Gurrin, L.
Published 2010

Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12-year study

by Zaloumis, S., Allen, K., Bertalli, N., Turkovic, L., Delatycki, M., Nicoll, A., Mclaren, C., English, D., Hopper, J., Giles, G., Anderson, G., Olynyk, John, Powell, L., Gurrin, L., Bahlo, M., Vulpe, C., Forrest, S., Fletcher, A.
Published 2015

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer

by Osborne, N., Gurrin, N., Allen, K., Constantine, C., Delatycki, M., McLaren, C., Gertig, D., Anderson, G., Southey, M., Olynyk, John, Powell, L., Hopper, J., Giles, G., English, D.
Published 2010

The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis

by Gurrin, L., Osborne, N., Constantine, C., McLaren, C., English, D., Gertig, D., Delatycki, M., Southey, M., Hopper, J., Giles, G., Anderson, G., Olynyk, John, Powell, L., Allen, K.
Published 2008

Iron-overload-related disease in HFE hereditary hemochromatosis

by Allen, K., Gurrin, L., Constantine, C., Osborne, N., Delatycki, M., Nicoll, A., McLaren, C., Bahlo, M., Nisselle, A., Vulpe, C., Anderson, G., Southey, M., Giles, G., English, D., Hopper, J., Olynyk, John, Powell, L., Gertig, D.
Published 2008

Morphological predictors of BRCA1 germline mutations in young women with breast cancer

by Southey, M C, Ramus, S J, Dowty, J G, Smith, L D, Tesoriero, A A, Wong, E E M, Dite, G S, Jenkins, M A, Byrnes, G B, Winship, I, Phillips, K-A, Giles, G G, Hopper, J L
Published 2011

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

by Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., Phillips, K. A.
Published 2011

The TERT variant rs2736100 is associated with colorectal cancer risk

by Kinnersley, B, Migliorini, G, Broderick, P, Whiffin, N, Dobbins, S E, Casey, G, Hopper, J, Sieber, O, Lipton, L, Kerr, D J, Dunlop, M G, Tomlinson, I PM, Houlston, R S
Published 2012

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre

by MacInnis, R J, Bickerstaffe, A, Apicella, C, Dite, G S, Dowty, J G, Aujard, K, Phillips, K-A, Weideman, P, Lee, A, Terry, M B, Giles, G G, Southey, M C, Antoniou, A C, Hopper, J L
Published 2013